Mammography Market Size, Share & Industry Analysis, By Service (Screening Mammography Services, Diagnostic Mammography Services, and Mammography-guided Interventional Services), By Imaging Modality (2D Digital Mammography Services, 3D Digital Breast Tomosynthesis Services, Contrast-enhanced Mammography Services, and Others), By End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

The global mammography market size was valued at USD 13.86 billion in 2025. The market is projected to grow from USD 14.31 billion in 2026 to USD 19.37 billion by 2034, exhibiting a CAGR of 3.9% during the forecast period.

The mammography market comprises imaging services and technologies used to detect, diagnose, and monitor breast abnormalities, particularly breast cancer. The technique remains the gold standard for breast cancer screening, enabling early detection and improving survival rates through timely diagnosis and treatment. Market growth is attributed to the rising global incidence of breast cancer, increasing awareness regarding preventive healthcare, and widespread implementation of national breast cancer screening programs. Moreover, continuous technological advancements, including digital mammography, 3D digital breast tomosynthesis (DBT), artificial intelligence (AI)-assisted image interpretation, and contrast-enhanced mammography, are also projected to have a positive impact on market growth.

Key industry players, such as RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., and Fortis Healthcare Ltd., are focusing on developing various innovative technologies to offer better products with improved accuracy and efficiency.

MAMMOGRAPHY MARKET TRENDS

Growing Adoption of AI-Enabled 3D DBT is One of the Important Trends Observed in the Market

The market is witnessing a strong trend toward the adoption of AI-enabled 3D digital breast tomosynthesis systems. Hospitals and diagnostic imaging centers are increasingly shifting from conventional 2D mammography to advanced 3D mammography solutions as these systems provide better visualization of breast tissue, reduce tissue overlap, and improve cancer detection accuracy, especially among women with dense breasts. In addition, artificial intelligence is further strengthening this trend by helping radiologists detect suspicious lesions, prioritize complex cases, reduce reading time, and lower false-positive recalls. Moreover, the rising number of collaborations amongst market players and healthcare providers further supports this trend.   

• For instance, in April 2026, GE HealthCare expanded its collaboration with RadNet's DeepHealth to globally commercialize AI-powered mammography solutions by integrating DeepHealth's Breast Suite with Pristina Via, enhancing breast cancer detection, workflow efficiency, and clinical decision-making.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Growing Breast Cancer Screening Programs to Accelerate Market Growth

The expansion of organized breast cancer screening programs is one of the primary factors driving the market. Governments, healthcare organizations, and cancer societies across the globe continue to promote routine mammography examinations for women within recommended age groups to facilitate early detection and reduce breast cancer mortality. Moreover, increasing public awareness campaigns, improved reimbursement policies, and expanding diagnostic infrastructure have significantly increased screening participation rates across developed and developing countries.

• For instance, in April 2026, the NCCN updated its breast cancer screening guidelines to include AI-based mammogram risk assessment beginning at age 35, supporting the earlier identification of high-risk women and advancing personalized, risk-based breast cancer prevention strategies.

MARKET RESTRAINTS

High Cost of Advanced Mammography Systems to Deter Market Growth

Despite technological advancements, the high acquisition and maintenance costs associated with advanced mammography systems continue to limit the global mammography market growth. Digital breast tomosynthesis systems, AI-enabled imaging software, and contrast-enhanced mammography platforms require substantial capital investment, making adoption challenging for smaller healthcare facilities and rural diagnostic centers. In many low- and middle-income countries, inadequate healthcare funding and limited reimbursement policies further restrict access to advanced breast imaging technologies, reducing screening coverage among underserved populations.

MARKET OPPORTUNITIES

Shift Toward Personalized Breast Cancer Screening to Offer Lucrative Market Growth Opportunities

The shift toward personalized breast cancer screening presents a significant growth opportunity for the market. Healthcare providers are increasingly adopting risk-based screening strategies that consider factors such as breast density, genetic predisposition, family history, and AI-driven risk assessment to determine individualized screening intervals and imaging modalities. This approach enables earlier detection among high-risk women while optimizing healthcare resources. Furthermore, increasing investments in mobile mammography units and breast screening programs in underserved regions will expand access to early diagnosis, creating substantial long-term market opportunities.

MARKET CHALLENGES

Shortage of Skilled Breast Imaging Professionals to Pose a Critical Challenge to Market Growth

The growing volume of mammography examinations has increased the demand for experienced breast radiologists and trained imaging technologists. However, many healthcare systems continue to face shortages of qualified professionals capable of accurately interpreting complex mammography images. This workforce gap may delay diagnosis, increase reporting times, and reduce screening efficiency. Addressing this challenge requires continued investment in workforce training, AI-assisted diagnostic tools, and standardized breast imaging protocols to improve healthcare delivery.

Segmentation Analysis

By Service

Rising Breast Cancer Risk Among Aging Women Boosted Screening Mammography Services Segment Growth

Based on service, the market is divided into screening mammography services, diagnostic mammography services, and mammography-guided interventional services.

The screening mammography services segment held a major market share in 2025. The segment’s growth is attributed to increasing awareness of preventive healthcare, growing implementation of national breast cancer screening programs, and recommendations from healthcare organizations for routine mammography examinations. In addition, the active involvement of governments and healthcare providers is also expected to have a positive impact on segment growth. Moreover, the growing aging female population and rising incidence of breast cancer further strengthen demand for screening mammography services, supporting the segment’s dominant market position.

The mammography-guided interventional services segment is anticipated to rise with a CAGR of 5.9% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Imaging Modality

Superior Diagnostic Performance Offered by 3D Digital Breast Tomosynthesis Services Encourages Segment Growth

Based on imaging modality, the market is segmented into 2D digital mammography services, 3D digital breast tomosynthesis services, contrast-enhanced mammography services, and others.

In 2025, the 3D digital breast tomosynthesis services segment held a 50.6% share of the global market. 3D Digital Breast Tomosynthesis (DBT) services dominate the market owing to their superior diagnostic performance compared with conventional two-dimensional mammography. DBT captures multiple images from different angles, providing enhanced visualization of breast tissue while reducing tissue overlap. This significantly improves cancer detection rates, particularly in women with dense breast tissue, while lowering false-positive recall rates. Healthcare providers continue to replace conventional mammography systems with DBT technology to improve clinical outcomes and patient confidence.

The contrast-enhanced mammography services segment is anticipated to rise with a CAGR of 5.3% over the forecast period.  

By End-User

Early Adoption of Advanced  Mammography Technologies Fueled Hospitals & Specialty Clinics Segment Growth

Based on end-user, the market is segmented into hospitals, specialty clinics, diagnostic centers, and others.

In 2025, the hospitals segment held the highest market share. Hospitals account for the largest share of the market due to their advanced imaging infrastructure and comprehensive breast cancer care capabilities. Most hospitals provide integrated screening, diagnostic imaging, biopsy, surgery, oncology, and follow-up care under one facility, making them the preferred destination for breast cancer management. Hospitals are also among the earliest adopters of advanced mammography technologies, including digital breast tomosynthesis, AI-assisted image analysis, and contrast-enhanced mammography systems. Furthermore, the segment is set to hold a 43.9% share in 2026.

The specialty clinics segment is projected to grow at a CAGR of 4.5% during the forecast period.

Mammography Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant mammography market share in 2024, valued at USD 9.83 billion, and also maintained its leading market position in 2025, with USD 10.13 billion. The regional growth is attributed to strong healthcare infrastructure, favorable reimbursement, and widespread adoption of advanced breast imaging technologies.

U.S. Mammography Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is expected to reach around USD 10.11 billion in 2026, accounting for roughly 70.6% of global sales.

Europe

Europe is projected to record a growth rate of 3.9% during the forecast period. The market is expected to reach USD 2.13 billion in 2026. The region is estimated to witness considerable market growth due to organized population-based breast cancer screening programs, advanced diagnostic infrastructure, and strong government support for early detection.

U.K. Mammography Market

The U.K. market in 2026 is estimated to reach around USD 0.24 billion, representing roughly 1.7% of global revenues.

Germany Mammography Market

Germany’s market is projected to reach approximately USD 0.40 billion in 2026, equivalent to around 2.8% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 1.18 billion in 2026 and secure the position of the third-largest region in the market. Asia Pacific is expected to witness strong growth in the market due to rising breast cancer incidence, growing healthcare expenditure, improving diagnostic infrastructure, and increasing awareness about early breast cancer detection.

Japan Mammography Market

The Japan market is estimated to touch around USD 0.33 billion in 2026, accounting for roughly 2.3% of global revenues.

China Mammography Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues standing at around USD 0.51 billion, representing roughly 3.6% of global sales.

India Mammography Market

The Indian market is estimated to reach around USD 0.08 billion in 2026, accounting for roughly 0.5% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market during the forecast period. The Latin America market is set to reach a valuation of USD 0.34 billion in 2026. In the Middle East & Africa, the GCC is set to reach USD 0.08 billion in 2026.

South Africa Mammography Market

The South Africa market is projected to reach around USD 0.03 billion in 2026, representing roughly 0.22% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Key Players Focus on Collaborations to Boost their Market Share

The global mammography market holds a semi-consolidated market structure, with prominent players such as RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., and Fortis Healthcare Ltd. The significant market share held by these companies is due to numerous strategic initiatives, including distribution collaborations and implementation of new programs.

• For instance, in June 2026, FUJIFILM India announced the first installation of its AI-powered AMULET SOPHINITY digital mammography system at NM Medical in India. The platform combines low-dose imaging, AI-assisted workflows, and enhanced visualization, supporting the expansion of precision-led breast imaging services in the country.

Other notable players in the global market include InHealth Group, Affidea Group, Unilabs, Evidia Group, and I-MED Radiology Network. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.

LIST OF KEY MAMMOGRAPHY COMPANIES PROFILED

• RadNet, Inc. (U.S.)
• InHealth Group (U.K.)
• SimonMed Imaging (U.S.)
• Akumin Inc. (U.S.)
• Fortis Healthcare Ltd. (India)
• InHealth Group (U.K.)
• Affidea Group (Netherlands)
• Unilabs (Switzerland)
• Evidia Group (Germany)
• I-MED Radiology Network (Australia)

KEY INDUSTRY DEVELOPMENTS

• June 2026: Devonport Community and Health Services Centre opened Tasmania's first permanent breast screening clinic on the North West Coast. The new facility increased annual screening capacity and improved access to mammography services for more than 4,000 eligible women.
• April 2026: GE HealthCare expanded its collaboration with DeepHealth to globally deploy AI-powered mammography screening services. The collaboration integrates Breast Suite with Pristina Via to improve early breast cancer detection, streamline radiology workflows, and expand access to personalized breast screening programs.
• April 2026: The National Comprehensive Cancer Network (NCCN) incorporated AI-based mammographic risk assessment into its breast cancer screening guidelines beginning at age 35. The updated guidelines support personalized screening services and earlier identification of women at elevated risk of breast cancer.
• December 2025: SP Medifort Hospital partnered with Rotary District 3211 to launch free AI-powered thermal mammography screening camps across Kerala. The initiative expands community-based breast cancer screening services and improves access to early diagnosis.
• November 2025: Wichita Radiological Group selected DeepHealth's Operations Suite to modernize its imaging operations. The platform supports more connected breast imaging services, improved patient coordination, and more efficient mammography workflow management across multiple facilities.

REPORT COVERAGE

The global mammography market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, and key industry developments. The global market research report also provides a detailed competitive landscape with information on the market share and profiles of key players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation